Diagnosis and treatment of testicular tumors;Diagnostik und therapie von hodentumoren

Urologe - Ausgabe A

Volumn 41, Issue 4, 2002, Pages 374-387

  Albers, P ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

CANCER REGRESSION; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; EJACULATION; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; REVIEW; RISK FACTOR; SEMINOMA; TESTIS TUMOR; TREATMENT INDICATION;

EID: 0036937850     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-002-0219-x     Document Type: Review

References (5)

1. WHO Daten (2001) www.globocan.www.iarc
2. Krege S, Souchon R, Schmoll HJ (2001) for the German Testicular Cancer Study Group (GTCSG) Interdisciplinary consensus on diagnosis and treatment of testicular germ cell tumors: result of an update conference on evidence-based medicine (EBM). Eur Urol 40: 372-391
3. Pilar Laguna M, Pizzocaro G, Klepp Olbojn et al. (2001) EAU Guidelines on Testicular Cancer. Eur Urol 40: 102-110
4. Mostofi FK, Sesterhenn IA (1998) Histological typing of testis tumors, 2nd ed. WHO International Histological Classification of Tumors. Springer, Berlin Heidelberg New York Tokio
5. Albers et al. (2001) ASCO